Search Results - Pablo Mir
- Showing 1 - 20 results of 47
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Cortical volumetry and longitudinal cognitive changes in Parkinson’s disease: insights from the COPPADIS cohort by Tania Álvarez-Avellón, Carmen Solares, Juan César Álvarez Carriles, Pablo Franco‐Rosado, Patricia Diaz‐Galvan, Diego Santos‐García, Pablo Mir, Manuel Menéndez‐González
Published 2025Artigo -
8
-
9
COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multice... by Diego Santos‐García, Pablo Mir, Esther Cubo, Lydia Vela, María Rodríguez‐Oroz, Marı́a José Martı́, José Matías Arbelo, Jon Infante, Jaime Kulisevsky, Pablo Martínez‐Martín
Published 2016Artigo -
10
Effect Modification between Genes and Environment and Parkinson's Disease Risk by María Teresa Periñán, Kajsa Brolin, Sara Bandrés‐Ciga, Cornelis Blauwendraat, Christine Klein, Ziv Gan‐Or, Andrew Singleton, Pilar Gómez‐Garre, Maria Swanberg, Pablo Mir, Alastair Noyce
Published 2022Revisão -
11
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients by Iris Trender‐Gerhard, Mary G. Sweeney, Petra Schwingenschuh, Pablo Mir, Mark J. Edwards, Alexander Gerhard, James M. Polke, Michael G. Hanna, Mary B. Davis, Nicholas Wood, K P Bhatia
Published 2009Artigo -
12
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs) by Laura Silveira‐Moriyama, Petra Schwingenschuh, A. O’Donnell, Susanne A. Schneider, Pablo Mir, F. Carrillo, Carmen Terranova, Aviva Petrie, Donald G. Grosset, Niall Quinn, K P Bhatia, Andrew J. Lees
Published 2009Artigo -
13
GBA Variants Influence Motor and Non-Motor Features of Parkinson’s Disease by Silvia Jesús, Ismael Huertas, Inmaculada Bernal‐Bernal, Marta Bonilla‐Toribio, María T. Cáceres‐Redondo, Laura Vargas‐González, Myriam Gómez-Llamas, Fátima Carrillo, Enrique J. Calderón, Manuel Carballo, Pilar Gómez‐Garre, Pablo Mir
Published 2016Artigo -
14
Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease by María Teresa Periñán, Daniel Macías‐García, Silvia Jesús, Juan Francisco Martín‐Rodríguez, Laura Muñoz‐Delgado, María Valle Jiménez‐Jaraba, Dolores Buiza‐Rueda, Marta Bonilla‐Toribio, Astrid Adarmes‐Gómez, Pilar Gómez‐Garre, Pablo Mir
Published 2022Revisão -
15
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement by Alberto Albanese, Giovanni Abbruzzese, Dirk Dressler, Wojciech Dużyński, Svetlana Khatkova, Maria José Martí, Pablo Mir, Cesare Montecucco, Elena Moro, Michaela M. Pinter, Maja Relja, Emmanuel Roze, Inger Marie Skogseid, С.Л. Тимербаева, Charalampos Tzoulis
Published 2015Revisão -
16
Tremor stability index: a new tool for differential diagnosis in tremor syndromes by Lazzaro di Biase, John‐Stuart Brittain, Syed Ahmar Shah, David J. Pedrosa, Hayriye Cagnan, Alexandre Mathy, Chiung Chu Chen, Juan Francisco Martín‐Rodríguez, Pablo Mir, Lars Timmerman, Petra Schwingenschuh, Kailash P. Bhatia, Vincenzo Di Lazzaro, Peter Brown
Published 2017Artigo -
17
Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint by Alfons Schnitzler, Pablo Mir, Matthew Brodsky, L. Verhagen, Sergiu Groppa, Ramiro Álvarez, Andrew Evans, Marta Blázquez Estrada, Sean J. Nagel, Julie G. Pilitsis, Monika Pötter‐Nerger, Winona Tse, Leonardo Almeida, Nestor Tomycz, Joohi Jimenez‐Shahed, Witold Libionka, Fátima Carrillo, Christian J. Hartmann, Stefan Jun Groiss, Martin Gläser, Florence Defresne, Edward Karst, Binith Cheeran, Jan Vesper, Alfons Schnitzler, Jan Vesper, Pablo Mir, Leonardo Verhagen, Nestor Tomcyz, Christian J. Hartmann, Sergiu Groppa, Ramiro Álvarez, Julie G. Pilitsis, Monika Pötter‐Nerger, Stefan Jun Groiss, Matthew Brodsky
Published 2021Artigo -
18
European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies by Günther Deuschl, Angelo Antonini, João Costa, Katarzyna Śmiłowska, Daniela Berg, Jean‐Christophe Corvol, Giovanni Fabbrini, Joaquim J. Ferreira, Thomas Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evžen Růžička, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro
Published 2022Artigo -
19
European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies by Günther Deuschl, Angelo Antonini, João Costa, Katarzyna Śmiłowska, Daniela Berg, Jean‐Christophe Corvol, Giovanni Fabbrini, Joaquim J. Ferreira, Thomas Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evžen Růžička, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro
Published 2022Revisão -
20
Enfermedad de Parkinson avanzada. Características clínicas y tratamiento (parte I) by Jaime Kulisevsky, M. R. Luquín, José Matías Arbelo, J A Burguera, F. Carrillo, A. Castro, J. Chacón, Pedro Ruiz, E. Lezcano, Pablo Mir, Juan Carlos Martínez‐Castrillo, Irene Martínez‐Torres, Vıctor Puente, Ángel Sesar, F. Valldeoriola-Serra, R. Yañez
Published 2013Revisão
Search Tools:
Related Subjects
Medicine
Disease
Internal medicine
Parkinson's disease
Psychology
Biology
Genetics
Pathology
Neuroscience
Gene
Psychiatry
Physical medicine and rehabilitation
Dementia
Physical therapy
Neurology
Cohort
Deep brain stimulation
Genotype
Cognition
Movement disorders
Pediatrics
Population
Alzheimer's disease
Association (psychology)
Bioinformatics
Cognitive impairment
Dopamine
Dopaminergic
Environmental health
Nursing